Wang B C, Bloxham D D, Goetz K L
J Pharmacol Exp Ther. 1977 Nov;203(2):442-8.
Dipivalyl derivatives of epinephrine, norepinephrine and isoproterenol were injected intravenously into conscious dogs while cardiovascular variables were monitored. The dipivalyl compounds produced cardiovascular effects that were comparable to those produced by their respective parent catecholamines except that the responses had a delayed onset and a prolonged duration. The catecholamines were more potent than their derivatives; norepinephrine was 28 times, epinephrine 15 times and isoproterenol 1.7 times as effective as their respective dipivalyl derivatives. Alpha or beta adrenergic responses to the dipivalyl compounds were attenuated or abolished after alpha adrenergic blockade (phenoxybenzamine or phentolamine), or beta adrenergic blockade (propranolol), respectively, or combined alpha and beta blockade. Since other evidence indicates that the dipivalyl derivatives themselves are inactive, our results suggest that these compounds act as prodrugs that exert their cardiovascular effects only after they are biotransformed to catecholamines.
将肾上腺素、去甲肾上腺素和异丙肾上腺素的二特戊酰衍生物静脉注射到清醒的犬体内,同时监测心血管变量。二特戊酰化合物产生的心血管效应与其各自的母体儿茶酚胺产生的效应相当,只是反应的起效延迟且持续时间延长。儿茶酚胺比其衍生物更有效;去甲肾上腺素的效力是其相应二特戊酰衍生物的28倍,肾上腺素是15倍,异丙肾上腺素是1.7倍。分别用α肾上腺素能阻滞剂(酚苄明或酚妥拉明)或β肾上腺素能阻滞剂(普萘洛尔),或联合α和β阻滞剂后,对二特戊酰化合物的α或β肾上腺素能反应减弱或消除。由于其他证据表明二特戊酰衍生物本身无活性,我们的结果表明这些化合物作为前体药物,仅在生物转化为儿茶酚胺后才发挥其心血管效应。